Erythrocyte Catalase Activity in More Frequent Microcytic Hypochromic Anemia: Beta-Thalassemia Trait and Iron Deficiency Anemia

Table 2

Hematological parameters, iron status, and catalase according to pathology and sex (Media ± Standard Deviation).

Pathology; Sex	Age; years	HTO; L/L	HB; g/L	ECAT; MU/L	Fe; μg/dL	TIBC; μg/dL	SAT; %
IDA group
Female (6)	20 ± 19	0,31 ± 0,08	90 ± 32	68,3 ± 27,4	29 ± 10	344 ± 68	8 ± 3
Male (4)	19 ± 30	0,34 ± 0,04	95 ± 15	80,6 ± 8,1	22 ± 8	324 ± 79	7 ± 3
BTT group
Female (15)	34 ± 17	0,36 ± 0,02	108 ± 6	99,4 ± 25,9	84 ± 32	270 ± 56	31 ± 9
Male (6)	27 ± 6	0,39 ± 0,05	118 ± 16	104,0 ± 20,4	114 ± 83	272 ± 52	44 ± 32
N group
Female (39)	36 ± 13	0,41 ± 0,02	137 ± 10	96,8 ± 17,5	81 ± 18	301 ± 54	28 ± 11
Male (28)	37 ± 15	0,44 ± 0,02	147 ± 9	93,1 ± 15,4	94 ± 28	282 ± 38	34 ± 11

< 0,05 between IDA and N groups by sex; < 0,05 between BTT and N groups by sex; < 0,05 between IDA and BTT women.
IDA, iron deficiency anemia; BTT, β-thalassemia trait; N, normal; HTO, hematocrit; HB, hemoglobin; ECAT, erythrocyte catalase activity; Fe, iron; TIBC, total iron binding capacity; SAT, transferrin saturation.